Presentation Decks
ASX Announcements
Stock Information
Emyria Limited (ASX:EMD ) is an Australian public company that commenced trading on the Australian Securities Exchange (ASX) on 12 February 2020, a data-backed, drug development company that elevates clinical care and delivers deeper clinical insights.
Reports & Updates
Annual Reports
Quarterly Reports
Investor Communication Update
Following the passing of the Corporations Amendments (meetings and Documents) Act 2022 in February 2022, the way we communicate regarding Notices of Meeting and Annual Reports has changed.
More information, including contact details for updates to our shares and options register, is available at the button below.